MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma.
Yang C, Ma X, Guan G, Liu H, Yang Y, Niu Q, Wu Z, Jiang Y, Bian C, Zang Y, Zhuang L.
Yang C, et al. Among authors: ma x.
FASEB J. 2019 Jan;33(1):1456-1467. doi: 10.1096/fj.201801151R. Epub 2018 Aug 21.
FASEB J. 2019.
PMID: 30130435
Taken together, our results show that miR-766 affects HCC progression by modulating NR3C2 expression and is a possible new therapeutic target for patients with HCC.-Yang, C., Ma, X., Guan, G., Liu, H., Yang, Y., Niu, Q., Wu, Z., Jiang, Y., Bian, C., Zang, Y., Zhuang …
Taken together, our results show that miR-766 affects HCC progression by modulating NR3C2 expression and is a possible new therapeutic targe …